Caplin Point Laboratories Ltd (CAPLIPOINT) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 640544, "name": "Caplin Point Lab", "stock_name": "Caplin Point Lab", "full_name": "Caplin Point Laboratories Ltd", "name_url": "stocks-analysis/caplin-point-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "2,542.35", "chg": 21.8, "chgp": "0.86%", "dir": 1, "prev_price": "2,520.55", "mcapval": "19,294.00 Cr", "mcap": "Small Cap", "scripcode": 524742, "symbol": "CAPLIPOINT", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE475E01026", "curr_date": "Aug 18, 04:01 PM", "curr_time": "08:40 AM", "last_traded_at": "Aug 18, 04:01 PM IST", "bse_nse_vol": "72.98 k", "exc_status": "Active", "traded_date": "Aug 18, 2026", "traded_date_str": "2026 08 18", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/caplin-point-lab-640544-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Caplin Point Laboratories Upgraded to Buy on Strong Technical and Financial Performance", "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-upgraded-to-buy-on-strong-technical-and-financial-performance-4159112", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CaplinPointLabo_mojoScore_4159112.png", "date": "2026-08-18 08:44:35", "description": "Caplin Point Laboratories Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality. This upgrade, effective from 17 Aug 2026, underscores the company’s robust quarterly performance, sustained growth, and bullish market signals that have strengthened investor confidence in this small-cap pharmaceutical player." }, { "title": "Caplin Point Laboratories Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-technical-momentum-shifts-signal-bullish-outlook-4158761", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CaplinPointLabo_technicaldot_4158761.png", "date": "2026-08-18 08:04:15", "description": "Caplin Point Laboratories Ltd has exhibited a notable shift in technical momentum, upgrading its outlook from mildly bullish to bullish. This change is underpinned by strong signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting a positive trajectory for the pharmaceutical company’s stock in the near term." }, { "title": "Caplin Point Laboratories Declines 3.67%: Mixed Technical Signals Shape Weekly Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-declines-367-mixed-technical-signals-shape-weekly-trend-4155810", "imagepath": "", "date": "2026-08-15 16:05:48", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Aug 10:</strong> Stock rises 1.82% to Rs.2,622.00 on positive volume</p>\n <p><strong>Aug 11:</strong> Marginal gain of 0.08% to Rs.2,624.15 despite Sensex dip</p>\n <p><strong>Aug 12:</strong> Sharp decline of 5.68% to Rs.2,475.20 following downgrade</p>\n <p><strong>Aug 13:</strong> Mild recovery with 0.93% gain to Rs.2,498.25 amid technical shifts</p>\n <p><strong>Aug 14:</strong> Week closes with 0.71% loss at Rs.2,480.60</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,575.05</..." }, { "title": "Has Caplin Point Laboratories Ltd declared dividend?", "link": "https://www.marketsmojo.com/news/stocks-in-action/has-caplin-point-laboratories-ltd-declared-dividend-4154829", "imagepath": "", "date": "2026-08-14 23:31:35", "description": "Caplin Point Laboratories Ltd has declared a dividend.\n\nDividend Details:\n- Percentage announced: 200%\n- Amount per share: 4 per share\n- Ex-date: 18 Sep 26\n\nDividend Yield: 0.28%.\n\nTotal Returns by Period:\nIn the 3 Months period, the price return was 23.0%, the dividend return was 0.40%, leading to a total return of 23.4%.\n\nIn the 6 Months period, the price return was 43.61%, the dividend return was 0.47%, resulting in a total return of 44.08%.\n\nIn the 1 Year period, the price return was 16.62%, the dividend return was 0.52%, culminating in a total return of 17.14%.\n\nIn the 2 Years period, the price return was 59.55%, the dividend return was 0.90%, which brought the total return to 60.45%.\n\nIn the 3 Years period, the price return was 145.6%, the dividend return was 2.00%, leading to a total return of 147.6%.\n\nIn the 4 Years period, the price return was 213.7%, the dividend return was 3.29%, resulting in a t..." }, { "title": "Caplin Point Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4151234", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CaplinPointLabo_mojoScore_4151234.png", "date": "2026-08-13 08:22:38", "description": "Caplin Point Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 12 August 2026. This revision reflects a nuanced assessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite strong financial performance and consistent returns, evolving market dynamics and technical indicators have prompted a more cautious stance." }, { "title": "Caplin Point Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-ltd-sees-technical-momentum-shift-amid-mixed-signals-4150998", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CaplinPointLabo_technicaldot_4150998.png", "date": "2026-08-13 08:01:54", "description": "Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to demonstrate resilience with mixed technical indicator signals, warranting a closer examination of its price action and momentum dynamics." }, { "title": "Caplin Point Laboratories Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/caplin-point-laboratories-ltd-is-rated-buy-4142789", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/CaplinPointLabo_mojoScore_4142789.png", "date": "2026-08-08 10:10:28", "description": "Caplin Point Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Caplin Point Laboratories Gains 2.03%: 2 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/caplin-point-laboratories-gains-203-2-key-factors-driving-the-week-4131810", "imagepath": "", "date": "2026-08-01 16:08:59", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>27 Jul:</strong> Intraday high surge to Rs.2,638.95 (+7.48%)</p>\n <p><strong>28 Jul:</strong> Upgrade to Buy rating by MarketsMOJO</p>\n <p><strong>31 Jul:</strong> Week closes at Rs.2,514.70 (+2.03% weekly)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,464.65</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,514.70</div><div class=\"stat-change positive\">+2.03%</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">We..." }, { "title": "When is the next results date for Caplin Point Laboratories Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-caplin-point-laboratories-ltd-4129216", "imagepath": "", "date": "2026-07-30 23:17:06", "description": "The next results date for Caplin Point Laboratories Ltd is scheduled for 12 August 2026...." } ], "total": 672, "sid": "640544", "stock_news_url": "https://www.marketsmojo.com/news/caplin-point-laboratories-640544" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Change in Management", "datetime": "12-Aug-2026", "details": "The Board of Director in its meeting held today August 12 2026 approved the appointment of directors.", "source": "BSE" }, { "caption": "Corporate Action-Board approves Dividend", "datetime": "12-Aug-2026", "details": "Record date for Final Dividend is September 18 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation", "datetime": "12-Aug-2026", "details": "Investor Presentation for the Earnings Call for the Quarter ended June 30 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Caplin Point Laboratories Ltd has declared <strong>200%</strong> dividend, ex-date: 18 Sep 26", "dt": "2026-09-18", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Caplin Point Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 19 Oct 16", "dt": "2016-10-19", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Aug 10: Stock rises 1.82% to Rs.2,622.00 on positive volume

Aug 11: Marginal gain of 0.08% to Rs.2,624.15 despite Sensex dip

Aug 12: Sharp decline of 5.68% to Rs.2,475.20 following downgrade

Aug 13: Mild recovery with 0.93% gain to Rs.2,498.25 amid technical shifts

Aug 14: Week closes with 0.71% loss at Rs.2,480.60

Week Open

Rs.2,575.05Read full news article

Has Caplin Point Laboratories Ltd declared dividend?

2026-08-14 23:31:35

Caplin Point Laboratories Ltd has declared a dividend. Dividend Details: - Percentage announced: 200% - Amount per share: 4 per share - Ex-date: 18 Sep 26 Dividend Yield: 0.28%. Total Returns by Period: In the 3 Months period, the price return was 23.0%, the dividend return was 0.40%, leading to a total return of 23.4%. In the 6 Months period, the price return was 43.61%, the dividend return was 0.47%, resulting in a total return of 44.08%. In the 1 Year period, the price return was 16.62%, the dividend return was 0.52%, culminating in a total return of 17.14%. In the 2 Years period, the price return was 59.55%, the dividend return was 0.90%, which brought the total return to 60.45%. In the 3 Years period, the price return was 145.6%, the dividend return was 2.00%, leading to a total return of 147.6%. In the 4 Years period, the price return was 213.7%, the dividend return was 3.29%, resulting in a t...

Read full news article

Caplin Point Laboratories Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-08-13 08:22:38

Caplin Point Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 12 August 2026. This revision reflects a nuanced assessment across four critical parameters: quality, valuation, financial trend, and technicals. Despite strong financial performance and consistent returns, evolving market dynamics and technical indicators have prompted a more cautious stance.

Read full news article

Caplin Point Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Signals

2026-08-13 08:01:54

Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock continues to demonstrate resilience with mixed technical indicator signals, warranting a closer examination of its price action and momentum dynamics.

Read full news article

Caplin Point Laboratories Ltd is Rated Buy

2026-08-08 10:10:28

Caplin Point Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.